… We performed a prospective phase 2 study of MRgRT for localized prostate cancer to …
studied using both clinician-scored and patient-reported outcomes. A nonrandomized phase 2 …

… In this multicentre, open-label, single-arm, phase 2 study, patients aged at least 18 years
with histologically confirmed metastatic castration-resistant prostate cancer (mixed histology …

… tomography to stage men with high-risk prostate cancer for nodal or distant metastases,
and reliably detect sites of disease in men with suspected metastatic prostate cancer. …

… This study reports the findings of a phase 2 randomized clinical trial of observation vs
SABR in men … The study also shows the value of the prostate-specific membrane antigen (PSMA)–…

… in two randomised phase 2 studies. In the randomised PLATO study, patients received …
In conclusion, our study showed that abiraterone and enzalutamide have similar first-line …

… Our results, if confirmed in registration studies, would support the implementation of tumour
… -resistant prostate cancer, we designed TOPARP, an adaptive programme of serial phase 2 …

… , this study is the first international phase 2 trial to assess the antitumour activity and tolerability
of talazoparib in men with metastatic castration-resistant prostate cancers with alterations …

… study was first conceived and designed in 2011, molecular imaging with PET radiotracers
were not being done routinely for prostate cancer. … matter virtually any imaging study) had not …

… )-independent prostate cancer, or anaplastic prostate cancer, … for men with metastatic prostate
cancer. Approximately 20% … , a single-arm phase 2 clinical trial of single agent avelumab …

… We did a phase 1–2, open label, randomised study at two centres in … prostate cancer
clinicopathological criteria (AVPC-C), and used them to select patients for a single-group phase 2 …